VitroScreen Seminar - Substance-based medical device qualification and classification: Pre-clinical approaches to mechanism of action
ALTEX
.
2023;40(3):549-552.
doi: 10.14573/altex.2303301.
Authors
Marisa Meloni
1
,
Laura Brambilla
1
,
Francesco Carriero
1
,
Alessia Frabetti
2
,
Maria Grazia Leone
3
,
Giulia Magri
4
,
Chiara Novi
5
,
Christian Pellevoisin
6
,
Alessandra Sepe
7
,
Alessandra Semenzato
8
,
Laura Ceriotti
1
Affiliations
1
VitroScreen srl, Milan, Italy.
2
Kiwa Cermet, Granarolo dell'Emilia, Italy.
3
Italian Ministry of Health, Rome, Italy.
4
Confindustria Dispositivi Medici, Milan, Italy.
5
TÜV Rheinland Italia, Pogliano Milanese, Italy.
6
MatTek Life Sciences, Bratislava, Slovak Republic.
7
Istituto Superiore di Sanità, Rome, Italy.
8
Department of Pharmaceutical Sciences, University of Padova, Italy.
PMID:
37470353
DOI:
10.14573/altex.2303301
No abstract available
Publication types
Editorial